Avidity characterization of genetically engineered T-cells with novel and established approaches
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Avidity characterization of genetically engineered T-cells with novel and established approaches
Authors
Keywords
T-cell receptor, Affinity, Avidity, LigandTracer, xCELLigence, HLA binding, TARP, CMV pp65
Journal
BMC IMMUNOLOGY
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-13
DOI
10.1186/s12865-016-0162-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
- (2016) Junzo Hamanishi et al. International Journal of Clinical Oncology
- Cancer gene therapy with T cell receptors and chimeric antigen receptors
- (2015) Hans J Stauss et al. CURRENT OPINION IN PHARMACOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Codification of bidentate pMHC interaction with TCR and its co-receptor
- (2015) Ellis L. Reinherz et al. TRENDS IN IMMUNOLOGY
- Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+T Cells
- (2014) Keisuke Watanabe et al. JOURNAL OF IMMUNOLOGY
- Too Much of a Good Thing? Tim-3 and TCR Signaling in T Cell Exhaustion
- (2014) Robert L. Ferris et al. JOURNAL OF IMMUNOLOGY
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- To affinity and beyond: Harnessing the T Cell receptor for cancer immunotherapy
- (2014) Jessica E Thaxton et al. Human Vaccines & Immunotherapeutics
- Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells
- (2014) Giovanna Bossi et al. OncoImmunology
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Co-Receptor CD8-Mediated Modulation of T-Cell Receptor Functional Sensitivity and Epitope Recognition Degeneracy
- (2013) Barbara Szomolay et al. Frontiers in Immunology
- Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies
- (2012) Milos Aleksic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2+ prostate and breast cancer cells
- (2012) V. Hillerdal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search